BYAH Launches $2.45M Follow-On Offering at $0.112 Per Unit—Warrants Add Leverage for Investors
Broad Capital Raise Targets Expansion and Investor Flexibility
Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) has announced the pricing of its $2.45 million best-efforts follow-on public offering, setting the stage for an ambitious growth push in China’s skincare sector. Each of the 21,875,000 units is being offered at $0.112 apiece, with every unit including one Class A ordinary share and a warrant entitling investors to buy up to nine shares per unit at the same $0.112 exercise price, valid for one year from issuance.
Offering Structure Stands Out with Built-In Upside from Warrants
Unlike a simple equity raise, this offering provides buyers with both current and future optionality. Here are the key details:
| Total Units Offered | Unit Price (USD) | Shares per Unit | Warrants per Unit | Exercise Price (USD) | Potential Shares (Including Max Warrant Option) | Gross Proceeds (USD) |
|---|---|---|---|---|---|---|
| 21,875,000 | 0.112 | 1 | 1 (exercisable for up to 9 shares) | 0.112 | Up to 218,750,000 | 2,450,000 |
Each unit's warrant is instantly exercisable, further increasing the deal’s appeal to investors looking to leverage their position. If exercised to the maximum extent, up to nine Class A shares per unit could be delivered, magnifying the dilution—but also the upside—depending on the direction of BYAH's stock.
Expansion Capital Directed Toward China Market Growth
The company plans to deploy proceeds from the offering to expand its directly operated stores across China, feeding into a business model already supported by three corporate-run locations and thirty-nine franchise partners (as of April 2025). Park Ha’s focus remains on delivering accessible skincare solutions and its signature “light beauty experience,” which positions the franchise to capture more market share among value-driven consumers.
Deal Details and Market Timing Provide Strategic Advantage
The offering is expected to close on or around January 28, 2026, pending standard closing checks. With D. Boral Capital LLC acting as sole placement agent, the transaction is backed by industry professionals and proceeds are intended to fuel further growth and brand reinforcement in a competitive marketplace.
Investor Takeaway: Warrants Position BYAH for Volatility and Leverage
For investors, the inclusion of warrants at a matching price to the current offering makes this more than a straightforward equity deal. Should BYAH’s business plan drive strong topline growth or expansion improve market sentiment, the warrants could provide significant leveraged upside within a single year period. Yet, they also present dilution potential if exercised in full—an element buyers and existing holders should closely weigh.
As always, it’s worth monitoring how BYAH deploys this fresh capital and whether operational milestones (such as new store openings or franchise growth) track ahead of plan. Ultimately, this deal gives investors both exposure and leverage, with a timeline that will force a quick assessment on whether Park Ha’s expansion thesis pays off.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI

